Builds a forward-looking clinical strategy informed by the drug pipeline, emerging therapies, medical and specialty drug trends, clinical evidence, market dynamics, competitive intelligence, and current and future health-plan market needs that drives affordability and appropriate utilization through evidence-based coverage criteria, formulary and utilization-management strategies, site-of-care and medical-drug programs, biosimilar and therapeutic substitution opportunities, and high-value clinical interventions. Builds and develops a high-performing leadership and clinical team through clear priorities, role clarity, coaching, succession planning, performance management, professional development, and thoughtful workforce and capacity planning; fosters a culture of curiosity, accountability, psychological safety, evidence-based challenge, collaboration, innovation, and continuous improvement that empowers team members to make decisions at the appropriate level and learn through transformation.